Ozempic, Wegovy introduced in Kenya as diabetes, obesity burden grows

Ozempic and Wegovy come to Kenya as diabetes and obesity rise

Novo Nordisk Africa Head Malika De Maillard said the scale of diabetes and obesity across the continent demonstrated the need for stronger health responses.

Kenya Launches Ozempic, Wegovy for Diabetes, Obesity; Cost Barrier

NAIROBI, Kenya, September 12 — Kenya has broadened its treatment options for diabetes and obesity with the introduction of Ozempic and Wegovy, though medical...

Ozempic, Wegovy enter Kenya as diabetes, obesity burden mounts

NAIROBI, Kenya, Sep 12— Kenya has expanded its treatment options for diabetes and obesity with the introduction of Ozempic and Wegovy, but experts say the impact of the new medicines…

Ozempic, Wegovy introduced in Kenya as diabetes, obesity burden grows

The introduction of Ozempic and Wegovy in Kenya is drawing attention to the country’s growing cardio-metabolic health burden, as healthcare experts call for a more comprehensive approach to the prevention and management of type 2 diabetes, obesity and related conditions. Novo Nordisk hosted a scientific launch event in Nairobi on Saturday to introduce Ozempic for the management of […]